{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:58:19Z","timestamp":1785484699978,"version":"3.56.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.lrr.2026.100565","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T17:17:00Z","timestamp":1768324620000},"page":"100565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Survival predictors in Vietnamese elderly AML patients treated with decitabine: Real-world evidence from a low- and middle-income country"],"prefix":"10.1016","volume":"25","author":[{"given":"Ha Thanh","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quoc Khanh","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2502-6324","authenticated-orcid":false,"given":"Quoc Nhat","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van Nam","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Van Anh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Pham-The","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lrr.2026.100565_bib0001","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.lrr.2026.100565_bib0002","doi-asserted-by":"crossref","DOI":"10.1177\/20406207231208979","article-title":"Low-dose decitabine for previously untreated acute myeloid leukemia ineligible for intensive chemotherapy aged 65\u2009years or older: a prospective study based on comprehensive geriatric assessment","volume":"14","author":"Feng","year":"2023","journal-title":"Ther. Adv. Hematol."},{"issue":"2","key":"10.1016\/j.lrr.2026.100565_bib0003","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/17843286.2019.1665233","article-title":"Real-world data confirming the efficacy and safety of decitabine in acute myeloid leukaemia \u2013 results from a retrospective Belgian registry study","volume":"76","author":"Meers","year":"2021","journal-title":"Acta Clin. Belg."},{"issue":"2","key":"10.1016\/j.lrr.2026.100565_bib0004","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood-2005-10-4149","article-title":"Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia","volume":"108","author":"Cheson","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lrr.2026.100565_bib0005","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.lrr.2026.100565_bib0006","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1080\/10428194.2020.1780587","article-title":"The prognostic value of plasma fibrinogen level in patients with acute myeloid leukemia: a systematic review and meta-analysis","volume":"61","author":"Zhang","year":"2020","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.lrr.2026.100565_bib0007","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajh.24252","article-title":"Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)","volume":"91","author":"DiNardo","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.lrr.2026.100565_bib0008","first-page":"1","article-title":"Factors influencing the prognosis of acute myeloid leukemia","volume":"2021","author":"Zhu","year":"2021","journal-title":"Clin. Oncol. Res."},{"key":"10.1016\/j.lrr.2026.100565_bib0009","article-title":"Differences in healthcare services utilization between urban and rural older persons in vietnam: evidence from a national survey","volume":"62","author":"Doan","year":"2025","journal-title":"Inquiry"},{"issue":"8","key":"10.1016\/j.lrr.2026.100565_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235503","article-title":"Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults","volume":"15","author":"Yoo","year":"2020","journal-title":"PloS one"},{"issue":"25","key":"10.1016\/j.lrr.2026.100565_bib0011","doi-asserted-by":"crossref","first-page":"41498","DOI":"10.18632\/oncotarget.17241","article-title":"Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: a systematic review and meta-analysis","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.lrr.2026.100565_bib0012","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.24996\/ijs.2021.62.5.9","article-title":"Evaluation of some biochemical parameters and hormones in patients with acute myeloid leukemia in Iraq","volume":"62","author":"Jumaah","year":"2021","journal-title":"Iraqi J. Sci."},{"issue":"1","key":"10.1016\/j.lrr.2026.100565_bib0013","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.sjbs.2014.09.002","article-title":"Assessment of circulating biochemical markers and antioxidative status in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patients","volume":"22","author":"Rasool","year":"2015","journal-title":"Saudi J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.lrr.2026.100565_bib0014","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/leu.2011.207","article-title":"CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors","volume":"26","author":"Negrotto","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.lrr.2026.100565_bib0015","article-title":"Decitabine-induced changes in human myelodysplastic syndrome cell line SKM-1 are mediated by FOXO3A activation","volume":"2017","author":"Zeng","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.lrr.2026.100565_bib0016","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3349\/ymj.2017.58.1.35","article-title":"Decitabine as a first-line treatment for older adults newly diagnosed with acute myeloid leukemia","volume":"58","author":"Park","year":"2017","journal-title":"Yonsei Med. J."},{"issue":"6","key":"10.1016\/j.lrr.2026.100565_bib0017","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am. J. Epidemiol."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:11:11Z","timestamp":1785481871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048926000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":17,"alternative-id":["S2213048926000051"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100565","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival predictors in Vietnamese elderly AML patients treated with decitabine: Real-world evidence from a low- and middle-income country","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100565"}}